Glooko’s Remote Patient Monitoring for Diabetics

Glooko’s Remote Patient Monitoring for Diabetics

MPO's Sean Fenske speaks with Russ Johannesson of Glooko about the advantages of being able to monitor diabetes remotely.

By Sean Fenske, Editor-in-Chief08.31.21
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Russ Johannesson, CEO of Glooko. He speaks about the advantages remote monitoring offers to both physicians of diabetics as well as the patients themselves. He also offers insights into how his solution is used in conjunction with other device makers’ technologies. Specifically, the following questions are addressed.

  • What is Glooko and what do you do?
  • Does your solution work across all vendor technologies or are you partnered with select companies?
  • Given you were offering this technology prior to the pandemic, what did you learn about the use of the technology during the pandemic when people needed remote capabilities?
  • What are the next stages for advancement? Do you have functionality you’re working on incorporating?
  • What’s ahead? Where will Glooko be in five to ten years?

Listen to this episode and see what you think of remote monitoring of diabetes. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.
Related Searches:
Suggested For You